About BioAlliance Pharma
BioAlliance Pharma (Euronext Paris: Code Isin FR0010095596 - BIO) is a specialty pharmaceutical company focused on the development and marketing of innovative therapeutics targeting drug resistance in cancer, HIV, and opportunistic infections.
To attack the challenge of resistance, the company has multiple product opportunities in two broad proprietary drug delivery systems represented by the Lauriad® adhesive technology and the Transdrug® nanoparticle technology . Together with a New Entities (NE) program of molecules being developed as new drugs in oncology and HIV, the company is able to address worldwide markets in the EU, U.S, and Asia.
Facts about BioAlliance Pharma
Facts about BioAlliance Pharma
- Focus : Manufacturer
- Industry : Pharma
